Key result
Routine screening for inducible ischemia in asymptomatic diabetics with intermediate/high cardiovascular risk did not alter the 4.8-year cardiac event rate.
Why the study?
The baseline cardiovascular risk and the effect of screening for inducible ischemia on cardiac outcomes in higher-risk asymptomatic diabetic patients were uncertain.
Does routine screening for inducible ischemia reduce cardiac events in asymptomatic diabetics with intermediate or high cardiovascular risk?
RCT (n=1,123)
randomized
Does routine screening for inducible ischemia reduce cardiac events in asymptomatic diabetics with intermediate or high cardiovascular risk?
Answers are grounded in this paper and cite their sources.
Routine screening for inducible ischemia does not alter the low annual cardiac event rate in asymptomatic diabetics, even among those at intermediate or high baseline cardiovascular risk.
OBJECTIVE: To estimate baseline cardiovascular risk of 1,123 participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study and to assess cardiac event rates and the effect of screening on outcomes in these higher-risk participants. RESEARCH methods: Framingham score, UK Prospective Diabetes Study (UKPDS) risk engine, criteria of the French-Speaking Association for the Study of Diabetes and Metabolic Diseases, and the presence or absence of metabolic syndrome. Cardiac events (cardiac death or nonfatal myocardial infarction) were assessed during the 4.8-year follow-up in participants with intermediate/high cardiovascular risk. RESULTS: By various risk-stratification approaches, 53-75% of participants were defined as having intermediate or high cardiovascular risk. The prevalence of inducible ischemia on screening in these individuals ranged from 21 to 24%, similar to lower-risk participants (19-23%). Cardiac event rates were greater in intermediate-/high-risk versus low-risk groups, but this was only significant for the UKPDS risk engine (4.2 vs. 1.2%, P = 0.002). The annual cardiac event rate was <1% in all risk groups, except in the high-risk UKPDS group (∼2% per year). In intermediate-/high-risk participants randomized to screening versus no screening, 4.8-year cardiac event rates were similar (2.5-4.8% vs. 3.1-3.7%). CONCLUSIONS: A substantial portion of the DIAD population was defined as having intermediate/high baseline cardiovascular risk. Nevertheless, their annual cardiac event rate was low and not altered by routine screening for inducible ischemia.
No takes yet. Share an insight, caveat, or question.
Bansal et al. (2010) conducted an RCT in Asymptomatic diabetes (n=1,123). Routine screening for inducible ischemia vs. No screening was evaluated on Cardiac events (cardiac death or nonfatal myocardial infarction). Routine screening for inducible ischemia in asymptomatic diabetics with intermediate/high cardiovascular risk did not alter the 4.8-year cardiac event rate.
Synapse has enriched 10 related papers. Consider them for comparative context: